Univariate analysis of sexual dysfunction and associated factors
| Categorical variables | No sexual dysfunction (n=101), n (%) | Sexual dysfunction (n=101), n (%) | χ2 | P value |
| Male | 58 (57.4) | 52 (51.5) | 0.499 | 0.480 |
| Married or cohabited | 19 (18.8) | 13 (12.9) | 0.928 | 0.335 |
| Employed | 94 (93.1) | 80 (79.2) | 8.126 | 0.007* |
| Underlying medical illness | 13 (12.9) | 7 (6.9) | 1.387 | 0.238 |
| Diagnosis | 0.192 | 0.979 | ||
| Depressive disorder | 47 (46.5) | 50 (49.5) | ||
| Anxiety disorder | 27 (26.7) | 26 (25.7) | ||
| Schizophrenia | 16 (15.8) | 15 (14.9) | ||
| Bipolar disorder | 11 (10.9) | 10 (9.9) | ||
| History of electroconvulsive therapy | 2 (2.0) | 4 (4.0) | – | 0.683 |
| Current smoking | 17 (16.8) | 16 (15.8) | 0.000 | 1.000 |
| Current alcohol use | 33 (32.7) | 32 (31.7) | 0.000 | 1.000 |
| Any substance use | 36 (35.6) | 41 (40.6) | 0.336 | 0.562 |
| Antidepressant use | 77 (76.2) | 87 (86.1) | 2.625 | 0.104 |
| Antipsychotic agent use | 29 (28.7) | 36 (35.6) | 0.817 | 0.366 |
| Conventional agent | 6 (5.9) | 8 (7.9) | 0.077 | 0.783 |
| Atypical agent | 23 (22.8) | 33 (32.7) | 2.001 | 0.157 |
| Mood stabiliser use | 11 (10.9) | 15 (14.9) | 0.397 | 0.529 |
| Benzodiazepine use | 33 (32.7) | 56 (55.4) | 9.721 | 0.002* |
| Anticholinergic agent use | 9 (8.9) | 13 (12.9) | 0.816 | 0.499 |
| Medical drug use | 10 (9.9) | 7 (6.9) | 0.257 | 0.613 |
| Continuous variables | Mean (SD) or median [IQR] | t or U | P value | |
| Age (years) | 29.8 (9.0) | 30.6 (9.0) | −0.672 | 0.502 |
| Education (years) | 16.0 (3.1) | 16.0 (2.7) | 0.024 | 0.981 |
| BMI (kg/m2) | 24.9 (5.0) | 23.6 (4.6) | 1.974 | 0.050 |
| Illness duration (years) | 3.0 [1.0, 6.0] | 3.0 [1.0, 6.0] | 5 193.000 | 0.820 |
| BPRS scores | 25.7 (7.1) | 27.6 (7.4) | −1.859 | 0.064 |
| Quality of life | 89.1 (14.1) | 81.6 (14.5) | 3.731 | <0.001* |
| Antipsychotic dosage (mg CPZ equivalence) | 0 [0.0, 60.0] | 0 [0.0, 100.0] | 5 415.500 | 0.363 |
| Antidepressant dosage (mg FXT equivalence) | 20.0 [6.0, 26.3] | 20.0 [19.2, 40.0] | 6 366.000 | 0.002* |
| Benzodiazepine dosage (mg LOR equivalence) | 0 [0.0, 0.5] | 0.5 [0.0, 1.3] | 6 410.000 | 0.001* |
*p<0.05.
BMI, body mass index; BPRS, Brief Psychiatric Rating Scale; CPZ, chlorpromazine; FXT, fluoxetine; IQR, interquartile range; LOR, lorazepam; SD, standard deviation.